Prenetics Global Limited

NASDAQ:PRE

Medical - Diagnostics & Research

Healthcare
$10.35 +2.19%

+$0.43 today

Market cap
$185.61M
Beta
0.24
P/E (TTM)
-4.9
EPS (TTM)
-$4.18
52W Low $7.18High $23.63

Volume 1.58M

Average 0.22M

PRE Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Prenetics Global LimitedNASDAQ: PRE

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables rises 4.2% from a year ago

Net receivables stood at $11.88M at the end of Q1 FY2026, up 4.2% from a year earlier and up 298.2% from the prior quarter. Over 3 fiscal years it compounded at -58.8% a year.

Context

  • Net receivables amounted to 6.8% of total assets at the end of Q1 FY2026, up 1.2 pp from a year earlier.
  • Net receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +4.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$11.88M+298.2% QoQ
Last fiscal yearDec 2025
$2.98M-46.8% YoY
Year agoMar 2025
$11.39M+4.2% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.2%——
1 year-46.8%——
3-year CAGR-58.8%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
2.98M USD
Year-over-year change
-46.8%
4-year CAGR
-49.8%

Net Receivables vs competitors

How PRE compares with its peers on the latest reported figures

  • PRE's Mar 2026 net receivables of $11.88M is the 4th highest of the 11 companies compared; the peer median is $7.2M.
  • Its year-over-year change of +4.2% is the 4th highest of 11, against a peer median of -13.9%.
  • Net receivables amounts to 6.8% of total assets for PRE, versus a peer median of 7.2%.
PRE Competitors Peer median
Net Receivables for PRE and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ATLNAtlantic International Corp.Dec 2025$69.99M -4.7%+851.6%61.8%
OSUROraSure Technologies, Inc.Mar 2026$26.42M +22.8%-32.1%7.0%
STIMNeuronetics, Inc.Mar 2026$16.21M -39.7%+6.9%12.9%
PREPrenetics Global LimitedMar 2026$11.88M +4.2%-58.8%6.8%
PROFProfound Medical Corp.Mar 2026$9.45M +58.5%+15.8%12.8%
CDXSCodexis, Inc.Mar 2026$8.03M -30.7%-36.0%6.2%
SGMOSangamo Therapeutics, Inc.Mar 2026$6.36M +38.1%+33.0%10.6%
TLSITriSalus Life Sciences, Inc.Mar 2026$5.22M -4.4%+61.5%7.3%
MXCTMaxCyte, Inc.Mar 2026$4.25M -23.1%-32.1%2.2%
IMDXInsight Molecular Diagnostics Inc.Mar 2026$157K -95.6%-17.5%0.4%
ARMPArmata Pharmaceuticals, Inc.Mar 2026$47K -80.3%-37.5%0.1%
Peer median (excluding PRE) $7.2M-13.9%-5.3%7.2%

Competitors are the stored peer set for PRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents35.29M146.66M45.71M52.25M32.13M
Short-term Investments9.91M37.46M27.03M10.56M29.36M
Net Receivables47.05M42.5M5.29M5.61M2.98M
Inventory6.83M4.53M3.13M6.57M7.06M
Other Current Assets7.31M4.58M8.31M3.55M11.86M
Total Current Assets106.89M241.81M93.66M86.15M83.39M
Property, Plant & Equipment (Net)13.04M13.1M5.78M7.81M1.76M
Goodwill3.98M33.8M29.17M37.36M0
Intangible Assets23.83M14.79M13.43M11.57M44.7M
Long-term Investments0788.47K107.84M69.33M67M
Tax Assets79.7K243.45K28K00
Other Non-current Assets693.55K7.6M4.27M1.35M6.68M
Total Non-current Assets41.61M70.32M160.51M127.43M120.13M
Total Assets148.51M312.13M254.17M213.58M203.52M
Account Payables9.98M7.29M1.67M3.67M7.73M
Short-term Debt1.67M0001.33M
Tax Payables1.22M8.65M7.44M78K0
Deferred Revenue9.59M5.67M6.11M6.49M3.09M
Other Current Liabilities22.64M17.47M15.49M15.07M15.5M
Total Current Liabilities58.74M57.2M39.48M36.55M27.67M
Long-term Debt486.4M000437K
Deferred Tax Liabilities659.5K3.19M2.62M2.17M8K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities04.52M1.05M499K460K
Total Non-current Liabilities490.66M11.47M4.53M5.68M1.34M
Total Liabilities549.4M68.67M44.01M42.23M29.01M
Common Stock1.49K13.7K18K19K25K
Retained Earnings0(408.04M)(470.77M)(517.07M)0
Accumulated OCI(400.81M)(185.69M)(176.03M)(169.25M)0
Other Stockholders Equity(24K)000174.58M
Minority Interest(84.98K)6.4M3.8M957K(93K)
Total Equity(400.89M)243.46M210.16M171.35M174.51M
Total Debt491.67M6.65M2.37M5.77M2.2M
Net Debt456.38M(140.01M)(43.34M)(46.48M)(29.93M)

Prenetics Global Limited

NASDAQ:PRE

Intrinsic Alpha fair value

Locked

Current Price

$10.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.